  Bisphosphonates are generally used as therapeutic agents for bone diseases. However , previous reports on bisphosphonates-related osteonecrosis of the jaw ( BRONJ) demonstrated that inflammation<symptom> triggers and worsens the disease. Recently , polydeoxynucleotide ( PDRN) , an A